| TÍTULO | PROGRAMA | AÑO DE INICIO | AÑO DE FINALIZACIÓN | ROL SSPA |
| 3TR - Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions | H2020-IMI2-Innovative Medicines Initiative 2 | 2019 | 2026 | Coordinador |
| CIRCE - Joint action transfer of best practices in primary care. | EU4 Health Programme | 2023 | 2026 | Coordinador |
| Procure4Health - Healthcare Innovation Procurement Network. | HE-Cluster 1- Health | 2022 | 2025 | Coordinador |
| SIGNATURE - Single cells iN AuToimmUne inflammatoRy disEases. | H2020-MSCA-Marie Slodowska-Curie Actions | 2023 | 2025 | Coordinador |
| GenE-Humdi - Genome Editing to Treat Humans Diseases. | COST- European Cooperation In Science And Technology | 2022 | 2026 | Coordinador |
| EU-JAMRAI 2 - Joint Action Antimicrobial Resistance and Healthcare-Associated Infections 2 | EU4 Health Programme | 2024 | 2027 | Líder de WP |
| Transthyretin Amyloid Cardiomyopathy Study (iTAC Study) | International Atomic Energy Agency | 2021 | 2025 | Coordinador |
| OriON - Joint Action on Contribution to the Cancer Inequalities Registry to Monitor National Cancer Control Policies | EU4 Health Programme | 2024 | 2026 | Socio |
| ASSESS-DHT - DEVELOPMENT AND HARMONISATION OF METHODOLOGIES FOR ASSESSING DIGITAL HEALTH TECHNOLOGIES IN EUROPE | HE-CLUSTER 1- HEALTH | 2024 | 2026 | Socio |
| eprObes - Preventing lifetime obesity by early risk-factor identification, prognosis and intervention | HE-CLUSTER 1- HEALTH | 2023 | 2028 | Socio |
| halt-RONIN - Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies | HE-Cluster 1- Health | 2022 | 2026 | Líder de WP |
| CONECT4CHILDREN - European Paediatric Clinical Trials Network | H2020-IMI2-INNOVATIVE MEDICINES INITIATIVE 2 | 2018 | 2025 | Colaborador |
| RELECOV 2.0 - Consolidation of WGS and RT-PCR activities for SARS-CoV-2 in Spain towards sustainable use and integration of enhanced infrastructure and processes in the RELECOV network | EU4 Health Programme | 2023 | 2025 | Socio |
| HI-PRIX - New pricingand payment models for cost-effective and affordable health innovations | HE-Cluster 1- Health | 2023 | 2025 | Líder de WP |
| PRIMAVERA - Vaccines and Monoclonal antibodies: Predicting the Impact on antimicrobial Resistance and an Economic. | H2020-IMI2-Innovative Medicines Initiative 2 | 2021 | 2026 | Líder de WP |
| PROVIDE - Prediction and prevention of cardiovascular diseases in pre-diabetes and diabetes | EU4 Health Programme | 2023 | 2026 | Socio |
| NFP4Health - JOINT ACTION ON INCREASING THE CAPACITY OF NATIONAL FOCAL POINTS (NFP) | 3rd Health Programme | 2021 | 2026 | Líder de WP |
| EP Per Med - European Partnership for Personalised Medicine | HE-CLUSTER 1- HEALTH | 2024 | 2033 | Socio |
| TEAM-COACH: Training and Education in AntiMicrobial stewardship and infection prevention and COntrol in CHildren | EU4 Health Programme | 2023 | 2025 | Socio |
| GALATEA - diGitAL twin frAmework for TailorEd infAnt nutrition |
H2020-MSCA-MARIE SLODOWSKA-CURIE ACTIONS |
2024 | 2028 | Líder de WP |
| THCS - European Partnership on Transforming Health and Care System | HE-Cluster 1- Health | 2023 | 2029 | Socio |
| AMR-EDUCare - EduCation on Antimicrobial REsistance for the health workforce | EU4 Health Programme | 2023 | 2025 | Líder de WP |
| LUCIA. Understanding Lung Cancer related risk factors and their Impact | HE- Misión Cáncer | 2023 | 2026 | Socio |
| ERA4Health - Fostering a European Research Area for Health Research | HE-Cluster 1- Health | 2022 | 2029 | Socio |
| iRETINA - Development of a multilayered and bioprinted iPSC-derived retinal model with use in preclinical and toxicological testing | HE-MSCA-MARIE SLODOWSKA-CURIE ACTIONS | 2023 | 2026 | Único beneficiario |
| IDERHA-Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance | HE-IHI-INNOVATIVE HEALTH INITIATIVE | 2023 | 2028 | Socio |
| CGI-Clinics - Data-driven cancer genome interpretation for personalised cancer treatment | HE-Cluster 1- Health | 2022 | 2027 | Socio |
| LETERCOR - Prospective study to evaluate efficacy of 12 to 18 months immuno-guided prophylaxis with letermovir for prevention of CMV infection in lung transplant patients and comparison with a retrospective cohort treated with standard 12 months valganciclovir prophylaxis | MERCK SHARP & DOHME CORP – INVESTIGATOR STUDIES PROGRAM | 2023 | 2027 | Coordinador |
| EUCAIM European Federation for Cancer Images | Digital Europe Programme | 2023 | 2026 | Socio |
| UNMASK. UNveiling the pathobiology of metabolic dysfunction-associated steatotic liver disease (MASLD) for the discovery of novel therapeutics and biomarKers | ACCIÓN ESTRATÉGICA EN SALUD 2021-2023 | 2025 | 2027 | Coordinador |
| PARC - European Partnership on the Assessment of Risks from Chemicals | HE-Cluster 1- Health | 2022 | 2029 | Socio |
| UNITED4SURVEILLANCE - Union and National Capacity Building 4 IntegraTED Surveillance | EU4 Health Programme | 2023 | 2025 | Socio |
| DDBIOS-Droplet Digital PCR and PCR-free BIOSensors for the diagnosis of resistance-associated SNPs in Pneumocystis jirovecii | ACCIÓN ESTRATÉGICA EN SALUD 2021-2023 | 2024 | 2026 | Socio |
| IntelliLung - Intelligent Lung Support for Mechanically Ventilated Patients in the Intensive Care Unit. | HE-Cluster 1- Health | 2022 | 2027 | Socio |
| Schools4Health | EU4 Health Programme | 2022 | 2025 | Socio |
| AVOGADRO - Adapting Versatile Opportunities for Glycopeptide Antibiotics against Drug-Resistant Organisms | ERANETS/JPI- JPIAMR - JOINT PROGRAMMING INITIATIVE ON ANTIMICROBIAL RESISTANCE | 2025 | 2027 | Líder de WP |
| GRIPonNASH - GRIP on NASH: Global Research Initiative for Patient Screening on NASH | HE-IHI-INNOVATIVE HEALTH INITIATIVE | 2023 | 2027 | Líder de WP |
| ECRAID-Base - A pan-European network against infectious diseases | H2020-SC1-HEALTH, DEMOGRAPHIC CHANGE, AND WELLBEING | 2022 | 2026 | Líder de WP |
| CLIMAIR - Climate change and air contamination: Artificial Intelligence applied on the correlation between air pollutants and non-communicable respiratory diseases in Europe | HE-CLUSTER 1- HEALTH | 2025 | 2028 | Líder de WP |
|
e2-ducass - Digital tool intervention: bringing the health literacy to vulnerable populations for promoting physical activity, healthy diet patterns and mental and cardiovascular health |
HealthEquity 2023 | 2023 | 2026 | Coordinador |
| ProCure - Public Procurement Assessment in the Healthcare sector | EU4 Health Programme | 2023 | 2025 | Líder de WP |
| Predicting Response and Non-Response to Therapy in SLE | LUPUS RESEARCH | 2024 | 2026 | Único beneficiario |
| ResilNet-Resilience and vulnerability: from neural circuits to networks | ERANETS/JPI- NEURON | 2024 | 2026 | Socio |
| CARE4Diabetes - Reducing the burden of non-communicable diseases by providing a multi-disciplinary lifestyle treatment intervention for type 2 diabetes | EU4 Health Programme | 2023 | 2026 | Socio |
| AFFIRMO - Atrial Fibrillation Integrated Approach In Frail, Multimorbid, And Polymedicated Older People | H2020-SC1-Health, Demographic Change, and Wellbeing | 2021 | 2026 | Socio |
| HEALTH4EUKIDS - Joint action on the implementation of best practices and research results on prevention of non-communicable diseases and risk factors: health promotion and obesity prevention. | EU4 Health Programme | 2022 | 2025 | Socio |
| P2Med - IMIBIC Fellowship Programme for Personalised and Precision Medicine | H2020-MSCA-Marie Slodowska-Curie Actions | 2019 | 2025 | Único beneficiario |
| LRH-1/NR5A2_mediated immune coupied remodelling a wound healing | Cures | 2023 | 2026 | Único beneficiario |
| VOLABIOS. Validation and Comparitive Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early detection of Schizophrenia | HE-CLUSTER 1- HEALTH | 2025 | 2029 | Socio |
| EARLINESS - Early and sensitive detection of renal involvement and treatment responses in lupus patients using non-invasive biomarkers | HE-MSCA-MARIE SLODOWSKA-CURIE ACTIONS | 2025 | 2027 | Único beneficiario |
| PERSUADE - PERsistent atrial fibrillation: SUbstrate tArgeteD stratEgy | Partenariado ERA4Health | 2024 | 2026 | Coordinador |
| CARAMEL. CArdiovascular Risk Assessment in MEnopausaL women via multimodal data analysis enabling personalized prevention strategies | HE-CLUSTER 1- HEALTH | 2024 | 2029 | Socio |
Responsable de la información publicada:
Índice